Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-97 |
Sentence |
denotes |
[Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy]. |
TextSentencer_T2 |
98-106 |
Sentence |
denotes |
PURPOSE: |
TextSentencer_T3 |
107-213 |
Sentence |
denotes |
To know the treatment outcome of patients with multidrug-resistant tuberculosis (MDR-TB) during gestation. |
TextSentencer_T4 |
214-221 |
Sentence |
denotes |
METHOD: |
TextSentencer_T5 |
222-421 |
Sentence |
denotes |
Retrospective study of 3 cases of pregnant women, who were treated for MDR-TB with a regimen including pyrazinamide, ethambutol, para-aminosalicylic acid, cycloserine and amoxicillin-clavulanic acid. |
TextSentencer_T6 |
422-429 |
Sentence |
denotes |
RESULT: |
TextSentencer_T7 |
430-586 |
Sentence |
denotes |
All patients showed a good response to anti-tuberculosis chemotherapy without any serious adverse effect, and were culture-negative at the time of delivery. |
TextSentencer_T8 |
587-682 |
Sentence |
denotes |
Two patients delivered vaginally at weeks 40, and one patient delivered surgically at weeks 38. |
TextSentencer_T9 |
683-807 |
Sentence |
denotes |
All newborns were healthy, and their tuberculin skin tests and placental tissue examinations were negative for tuberculosis. |
TextSentencer_T10 |
808-947 |
Sentence |
denotes |
CONCLUSION: MDR-TB can be successfully treated during pregnancy by using a regimen including effective second-line anti-tuberculosis drugs. |
T1 |
0-97 |
Sentence |
denotes |
[Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy]. |
T2 |
98-106 |
Sentence |
denotes |
PURPOSE: |
T3 |
107-213 |
Sentence |
denotes |
To know the treatment outcome of patients with multidrug-resistant tuberculosis (MDR-TB) during gestation. |
T4 |
214-221 |
Sentence |
denotes |
METHOD: |
T5 |
222-421 |
Sentence |
denotes |
Retrospective study of 3 cases of pregnant women, who were treated for MDR-TB with a regimen including pyrazinamide, ethambutol, para-aminosalicylic acid, cycloserine and amoxicillin-clavulanic acid. |
T6 |
422-429 |
Sentence |
denotes |
RESULT: |
T7 |
430-586 |
Sentence |
denotes |
All patients showed a good response to anti-tuberculosis chemotherapy without any serious adverse effect, and were culture-negative at the time of delivery. |
T8 |
587-682 |
Sentence |
denotes |
Two patients delivered vaginally at weeks 40, and one patient delivered surgically at weeks 38. |
T9 |
683-807 |
Sentence |
denotes |
All newborns were healthy, and their tuberculin skin tests and placental tissue examinations were negative for tuberculosis. |
T10 |
808-947 |
Sentence |
denotes |
CONCLUSION: MDR-TB can be successfully treated during pregnancy by using a regimen including effective second-line anti-tuberculosis drugs. |